{"id":189386,"date":"2018-02-21T21:35:01","date_gmt":"2018-02-21T21:35:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=189386"},"modified":"2018-02-21T21:35:01","modified_gmt":"2018-02-21T21:35:01","slug":"prefilled-syringes-drug-molecules-market-is-anticipated-to-register-57-cagr-through-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/prefilled-syringes-drug-molecules-market-is-anticipated-to-register-57-cagr-through-2027_189386.html","title":{"rendered":"Prefilled Syringes Drug Molecules Market is Anticipated to Register 5.7% CAGR through 2027"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Future Market Insightsrn”<\/div>\n<\/div>\n<\/div>\n
North America is projected to be one of the most important regions for prefilled syringes drug molecules. However, North America is also experiencing drug shortage in rapidly increasing frequencies, which has been tracked by both American Society of Health-System Pharmacists (ASHP) and the US FDA.<\/div>\n

Global Prefilled Syringes Drug Molecules Market: Snapshot<\/strong><\/p>\n

Prefilled syringes drug molecules are prefilled with medication by the manufactures and are supplied to end users in the ready-to-use form. The overall global investment in healthcare has increased in the last few years. Healthcare field solutions continue to be sought after to increase the quality of life, which provides significant opportunities for pharmaceutical companies. This has also contributed to the growth of various segments of the healthcare industry such as the prefilled syringes drug molecules market. A new research report by Future Market Insights titled ‘Prefilled Syringes Drug Molecules Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 – 2027’ <\/strong>briefs the scenario of the global prefilled syringes drug molecules market<\/a>. According to the market analysis, the global prefilled syringes drug molecules market is expected to reach a market valuation of over US$ 70 Bn by the end of 2027, growing at a CAGR of 5.7% during the forecast period.<\/p>\n

A sample of this report is available upon request @ https:\/\/www.futuremarketinsights.com\/reports\/sample\/REP-GB-3198<\/a><\/p>\n

Global Prefilled Syringes Drug Molecules Market: Drivers and Opportunities<\/strong><\/p>\n

The report indicates that revenue growth of the market is mainly driven by the effectiveness, convenience and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringes. In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings have increased the demand for prefilled syringes drug molecules. Manufacturers are focussing on introducing updated technologies and advanced products in order to attract customers. Pharmaceutical companies are introducing generic versions for cost-effective auto-injector devices and are targeting emerging regions such as the Asia Pacific, Middle East and others in order to sustain and grow in the global prefilled syringes drug molecules market.<\/p>\n

Global Prefilled Syringes Drug Molecules Market: Segmental Analysis<\/strong><\/p>\n